Noninferiority of OS with 3 Months Compared to 6 Months of Adjuvant Chemotherapy for Patients with High-Risk Stage III Colorectal Cancer By Ogkologos - January 20, 2026 138 0 Facebook Twitter Google+ Pinterest WhatsApp Final findings from the SCOT study Source RELATED ARTICLESMORE FROM AUTHOR ESMO Welcomes European Parliament (EP) Draft Report on Psychosocial Risks at Work (PSR) as a Critical Opportunity to Protect the Wellbeing of the Cancer... FDA Approves Nivolumab with Chemotherapy for Previously Untreated Hodgkin Lymphoma 2026 ESMO Breast Cancer Award Recipient Announced MOST POPULAR From smouldering ash to a gleaming temple for cancer research: The... April 26, 2023 Olaparib after Initial Treatment Delays Ovarian Cancer Progression November 20, 2018 Pink Speed Bump Reminds Drivers to Schedule Their Yearly Mammograms November 1, 2019 Immunotherapy after Surgery Shows Long-Term Benefits for High-Risk Bladder Cancer March 21, 2023 Load more HOT NEWS Ovarian Cancer Studies Aim to Reduce Racial Disparities, Improve Outcomes Even If Insured, People with Advanced Cancer Often Face Financial Problems EMA Recommends Granting a Marketing Authorisation for Equidacent How does processed and red meat cause cancer and how much...
